Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9985 to 9996 of 115915 entries
Sorted by: Best Match Show Resources per page
Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update.

Infectious agents and cancer

Granata V, Fusco R, Catalano O, Setola SV, de Lutio di Castelguidone E, Piccirillo M, Palaia R, Grassi R, Granata F, Izzo F, Petrillo A.
PMID: 27891175
Infect Agent Cancer. 2016 Nov 15;11:57. doi: 10.1186/s13027-016-0105-6. eCollection 2016.

Ductal adenocarcinoma of the pancreas is one of the most aggressive forms of cancer, with only a minority of cases being resectable at the moment of their diagnosis. The accurate detection and characterization of pancreatic carcinoma is very important...

Cite
Granata V, Fusco R, Catalano O, et al. Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update. Infect Agent Cancer. 2016;11:57doi: 10.1186/s13027-016-0105-6.
Granata, V., Fusco, R., Catalano, O., Setola, S. V., de Lutio di Castelguidone, E., Piccirillo, M., Palaia, R., Grassi, R., Granata, F., Izzo, F., & Petrillo, A. (2016). Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update. Infectious agents and cancer, 1157. https://doi.org/10.1186/s13027-016-0105-6
Granata, Vincenza, et al. "Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update." Infectious agents and cancer vol. 11 (2016): 57. doi: https://doi.org/10.1186/s13027-016-0105-6
Granata V, Fusco R, Catalano O, Setola SV, de Lutio di Castelguidone E, Piccirillo M, Palaia R, Grassi R, Granata F, Izzo F, Petrillo A. Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update. Infect Agent Cancer. 2016 Nov 15;11:57. doi: 10.1186/s13027-016-0105-6. eCollection 2016. PMID: 27891175; PMCID: PMC5111267.
Copy Download .nbib Format: NLM
Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?.

World journal of hepatology

Amorim VB, Parente DB, Paiva FF, Oliveira Neto JA, Miranda AA, Moreira CC, Fernandes FF, Campos CFF, Leite NC, Perez RM, Rodrigues RS.
PMID: 33033571
World J Hepatol. 2020 Sep 27;12(9):661-671. doi: 10.4254/wjh.v12.i9.661.

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. The diagnosis of nonalcoholic steatohepatitis (NASH), the most severe form of NAFLD, is crucial and has prognostic and therapeutic implications. However, currently this diagnosis is...

Cite
Amorim VB, Parente DB, Paiva FF, et al. Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?. World J Hepatol. 2020;12(9):661-671doi: 10.4254/wjh.v12.i9.661.
Amorim, V. B., Parente, D. B., Paiva, F. F., Oliveira Neto, J. A., Miranda, A. A., Moreira, C. C., Fernandes, F. F., Campos, C. F. F., Leite, N. C., Perez, R. M., & Rodrigues, R. S. (2020). Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?. World journal of hepatology, 12(9), 661-671. https://doi.org/10.4254/wjh.v12.i9.661
Amorim, Viviane Brandão, et al. "Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?." World journal of hepatology vol. 12,9 (2020): 661-671. doi: https://doi.org/10.4254/wjh.v12.i9.661
Amorim VB, Parente DB, Paiva FF, Oliveira Neto JA, Miranda AA, Moreira CC, Fernandes FF, Campos CFF, Leite NC, Perez RM, Rodrigues RS. Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?. World J Hepatol. 2020 Sep 27;12(9):661-671. doi: 10.4254/wjh.v12.i9.661. PMID: 33033571; PMCID: PMC7522564.
Copy Download .nbib Format: NLM
Cisplatin-induced regulation of signal transduction pathways and transcription factors in p53-mutated subclone variants of hepatoma cells: Potential application for therapeutic targeting.

Oncology letters

Kuo JR, Shang HS, Ho CT, Lai KG, Liu TZ, Chen YJ, Chiou JF.
PMID: 27895723
Oncol Lett. 2016 Nov;12(5):3723-3730. doi: 10.3892/ol.2016.5181. Epub 2016 Sep 23.

Cisplatin is commonly recognized as a DNA-damaging drug; however, its versatile antitumor effects have been demonstrated to extend beyond this narrow functional attribute. The present study determined how cisplatin regulates alternative pathways and transcription factors to exert its additional...

Cite
Kuo JR, Shang HS, Ho CT, et al. Cisplatin-induced regulation of signal transduction pathways and transcription factors in p53-mutated subclone variants of hepatoma cells: Potential application for therapeutic targeting. Oncol Lett. 2016;12(5):3723-3730doi: 10.3892/ol.2016.5181.
Kuo, J. R., Shang, H. S., Ho, C. T., Lai, K. G., Liu, T. Z., Chen, Y. J., & Chiou, J. F. (2016). Cisplatin-induced regulation of signal transduction pathways and transcription factors in p53-mutated subclone variants of hepatoma cells: Potential application for therapeutic targeting. Oncology letters, 12(5), 3723-3730. https://doi.org/10.3892/ol.2016.5181
Kuo, Jinn-Rung, et al. "Cisplatin-induced regulation of signal transduction pathways and transcription factors in p53-mutated subclone variants of hepatoma cells: Potential application for therapeutic targeting." Oncology letters vol. 12,5 (2016): 3723-3730. doi: https://doi.org/10.3892/ol.2016.5181
Kuo JR, Shang HS, Ho CT, Lai KG, Liu TZ, Chen YJ, Chiou JF. Cisplatin-induced regulation of signal transduction pathways and transcription factors in p53-mutated subclone variants of hepatoma cells: Potential application for therapeutic targeting. Oncol Lett. 2016 Nov;12(5):3723-3730. doi: 10.3892/ol.2016.5181. Epub 2016 Sep 23. PMID: 27895723; PMCID: PMC5104157.
Copy Download .nbib Format: NLM
HCC surveillance results in earlier HCC detection: results from an Indian cohort.

SpringerPlus

Kohli A, Murphy AA, Agarwal C, Shivakumar B, Kottilil S, Polis MA, Subramanian GM, Midha V, Goyal O, Desai S, Sood A, Shah S.
PMID: 25392781
Springerplus. 2014 Oct 17;3:610. doi: 10.1186/2193-1801-3-610. eCollection 2014.

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide, with an increased incidence in South Asia. In order to describe the effect of surveillance for HCC with biannual ultrasound and alpha-fetoprotein (AFP) on diagnosis and...

Cite
Kohli A, Murphy AA, Agarwal C, et al. HCC surveillance results in earlier HCC detection: results from an Indian cohort. Springerplus. 2014;3:610doi: 10.1186/2193-1801-3-610.
Kohli, A., Murphy, A. A., Agarwal, C., Shivakumar, B., Kottilil, S., Polis, M. A., Subramanian, G. M., Midha, V., Goyal, O., Desai, S., Sood, A., & Shah, S. (2014). HCC surveillance results in earlier HCC detection: results from an Indian cohort. SpringerPlus, 3610. https://doi.org/10.1186/2193-1801-3-610
Kohli, Anita, et al. "HCC surveillance results in earlier HCC detection: results from an Indian cohort." SpringerPlus vol. 3 (2014): 610. doi: https://doi.org/10.1186/2193-1801-3-610
Kohli A, Murphy AA, Agarwal C, Shivakumar B, Kottilil S, Polis MA, Subramanian GM, Midha V, Goyal O, Desai S, Sood A, Shah S. HCC surveillance results in earlier HCC detection: results from an Indian cohort. Springerplus. 2014 Oct 17;3:610. doi: 10.1186/2193-1801-3-610. eCollection 2014. PMID: 25392781; PMCID: PMC4209002.
Copy Download .nbib Format: NLM
Brain structural abnormalities in behavior therapy-resistant obsessive-compulsive disorder revealed by voxel-based morphometry.

Neuropsychiatric disease and treatment

Hashimoto N, Nakaaki S, Kawaguchi A, Sato J, Kasai H, Nakamae T, Narumoto J, Miyata J, Furukawa TA, Mimura M.
PMID: 25349476
Neuropsychiatr Dis Treat. 2014 Oct 20;10:1987-96. doi: 10.2147/NDT.S69652. eCollection 2014.

BACKGROUND: Although several functional imaging studies have demonstrated that behavior therapy (BT) modifies the neural circuits involved in the pathogenesis of obsessive-compulsive disorder (OCD), the structural abnormalities underlying BT-resistant OCD remain unknown.METHODS: In this study, we examined the existence...

Cite
Hashimoto N, Nakaaki S, Kawaguchi A, et al. Brain structural abnormalities in behavior therapy-resistant obsessive-compulsive disorder revealed by voxel-based morphometry. Neuropsychiatr Dis Treat. 2014;10:1987-96doi: 10.2147/NDT.S69652.
Hashimoto, N., Nakaaki, S., Kawaguchi, A., Sato, J., Kasai, H., Nakamae, T., Narumoto, J., Miyata, J., Furukawa, T. A., & Mimura, M. (2014). Brain structural abnormalities in behavior therapy-resistant obsessive-compulsive disorder revealed by voxel-based morphometry. Neuropsychiatric disease and treatment, 101987-96. https://doi.org/10.2147/NDT.S69652
Hashimoto, Nobuhiko, et al. "Brain structural abnormalities in behavior therapy-resistant obsessive-compulsive disorder revealed by voxel-based morphometry." Neuropsychiatric disease and treatment vol. 10 (2014): 1987-96. doi: https://doi.org/10.2147/NDT.S69652
Hashimoto N, Nakaaki S, Kawaguchi A, Sato J, Kasai H, Nakamae T, Narumoto J, Miyata J, Furukawa TA, Mimura M. Brain structural abnormalities in behavior therapy-resistant obsessive-compulsive disorder revealed by voxel-based morphometry. Neuropsychiatr Dis Treat. 2014 Oct 20;10:1987-96. doi: 10.2147/NDT.S69652. eCollection 2014. PMID: 25349476; PMCID: PMC4208702.
Copy Download .nbib Format: NLM
Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine.

Annals of nuclear medicine

Guo H, Xu K, Duan G, Wen L, He Y.
PMID: 34727331
Ann Nucl Med. 2021 Nov 02; doi: 10.1007/s12149-021-01683-8. Epub 2021 Nov 02.

With a 5-year overall survival of approximately 20%, lung cancer has always been the number one cancer-specific killer all over the world. As a fusion of positron emission computed tomography (PET) and computed tomography (CT), PET/CT has revolutionized cancer...

Cite
Guo H, Xu K, Duan G, et al. Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine. Ann Nucl Med. 2021;doi: 10.1007/s12149-021-01683-8.
Guo, H., Xu, K., Duan, G., Wen, L., & He, Y. (2021). Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine. Annals of nuclear medicine, . https://doi.org/10.1007/s12149-021-01683-8
Guo, Haoyue, et al. "Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine." Annals of nuclear medicine vol. (2021). doi: https://doi.org/10.1007/s12149-021-01683-8
Guo H, Xu K, Duan G, Wen L, He Y. Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine. Ann Nucl Med. 2021 Nov 02; doi: 10.1007/s12149-021-01683-8. Epub 2021 Nov 02. PMID: 34727331.
Copy Download .nbib Format: NLM
Differences in COVID-19 Risk by Race and County-Level Social Determinants of Health among Veterans.

International journal of environmental research and public health

Abdel Magid HS, Ferguson JM, Van Cleve R, Purnell AL, Osborne TF.
PMID: 34948748
Int J Environ Res Public Health. 2021 Dec 13;18(24). doi: 10.3390/ijerph182413140.

COVID-19 disparities by area-level social determinants of health (SDH) have been a significant public health concern and may also be impacting U.S. Veterans. This retrospective analysis was designed to inform optimal care and prevention strategies at the U.S. Department...

Cite
Abdel Magid HS, Ferguson JM, Van Cleve R, et al. Differences in COVID-19 Risk by Race and County-Level Social Determinants of Health among Veterans. Int J Environ Res Public Health. 2021;18(24)doi: 10.3390/ijerph182413140.
Abdel Magid, H. S., Ferguson, J. M., Van Cleve, R., Purnell, A. L., & Osborne, T. F. (2021). Differences in COVID-19 Risk by Race and County-Level Social Determinants of Health among Veterans. International journal of environmental research and public health, 18(24), . https://doi.org/10.3390/ijerph182413140
Abdel Magid, Hoda S, et al. "Differences in COVID-19 Risk by Race and County-Level Social Determinants of Health among Veterans." International journal of environmental research and public health vol. 18,24 (2021). doi: https://doi.org/10.3390/ijerph182413140
Abdel Magid HS, Ferguson JM, Van Cleve R, Purnell AL, Osborne TF. Differences in COVID-19 Risk by Race and County-Level Social Determinants of Health among Veterans. Int J Environ Res Public Health. 2021 Dec 13;18(24). doi: 10.3390/ijerph182413140. PMID: 34948748; PMCID: PMC8701661.
Copy Download .nbib Format: NLM
The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan.

International journal of medical sciences

Wu CW, Ku YT, Huang CY, Hsieh PC, Lim KE, Tzeng IS, Lan CC, Wu YK, Hsu YC.
PMID: 34790062
Int J Med Sci. 2021 Oct 31;18(16):3861-3869. doi: 10.7150/ijms.64648. eCollection 2021.

No abstract available.

Cite
Wu CW, Ku YT, Huang CY, et al. The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan. Int J Med Sci. 2021;18(16):3861-3869doi: 10.7150/ijms.64648.
Wu, C. W., Ku, Y. T., Huang, C. Y., Hsieh, P. C., Lim, K. E., Tzeng, I. S., Lan, C. C., Wu, Y. K., & Hsu, Y. C. (2021). The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan. International journal of medical sciences, 18(16), 3861-3869. https://doi.org/10.7150/ijms.64648
Wu, Chih-Wei, et al. "The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan." International journal of medical sciences vol. 18,16 (2021): 3861-3869. doi: https://doi.org/10.7150/ijms.64648
Wu CW, Ku YT, Huang CY, Hsieh PC, Lim KE, Tzeng IS, Lan CC, Wu YK, Hsu YC. The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan. Int J Med Sci. 2021 Oct 31;18(16):3861-3869. doi: 10.7150/ijms.64648. eCollection 2021. PMID: 34790062; PMCID: PMC8579303.
Copy Download .nbib Format: NLM
Integrating expert knowledge for dementia risk prediction in individuals with mild cognitive impairment (MCI): a study protocol.

BMJ open

Wang M, Smith EE, Forkert ND, Chekouo T, Ismail Z, Ganesh A, Sajobi T.
PMID: 34764172
BMJ Open. 2021 Nov 11;11(11):e051185. doi: 10.1136/bmjopen-2021-051185.

INTRODUCTION: To date, there is no broadly accepted dementia risk score for use in individuals with mild cognitive impairment (MCI), partly because there are few large datasets available for model development. When evidence is limited, the knowledge and experience...

Cite
Wang M, Smith EE, Forkert ND, et al. Integrating expert knowledge for dementia risk prediction in individuals with mild cognitive impairment (MCI): a study protocol. BMJ Open. 2021;11(11):e051185doi: 10.1136/bmjopen-2021-051185.
Wang, M., Smith, E. E., Forkert, N. D., Chekouo, T., Ismail, Z., Ganesh, A., & Sajobi, T. (2021). Integrating expert knowledge for dementia risk prediction in individuals with mild cognitive impairment (MCI): a study protocol. BMJ open, 11(11), e051185. https://doi.org/10.1136/bmjopen-2021-051185
Wang, Meng, et al. "Integrating expert knowledge for dementia risk prediction in individuals with mild cognitive impairment (MCI): a study protocol." BMJ open vol. 11,11 (2021): e051185. doi: https://doi.org/10.1136/bmjopen-2021-051185
Wang M, Smith EE, Forkert ND, Chekouo T, Ismail Z, Ganesh A, Sajobi T. Integrating expert knowledge for dementia risk prediction in individuals with mild cognitive impairment (MCI): a study protocol. BMJ Open. 2021 Nov 11;11(11):e051185. doi: 10.1136/bmjopen-2021-051185. PMID: 34764172; PMCID: PMC8587594.
Copy Download .nbib Format: NLM
Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment.

Blood cells, molecules & diseases

Paskulin LD, Starosta RT, Bertholdo D, Vairo FP, Vedolin L, Schwartz IVD.
PMID: 34242856
Blood Cells Mol Dis. 2021 Sep;90:102591. doi: 10.1016/j.bcmd.2021.102591. Epub 2021 Jul 01.

INTRODUCTION: Gaucher disease (GD) is one of the most prevalent lysosomal disorders, with an estimated incidence of 1 in 40,000 live births worldwide. Skeletal involvement is one of the main features of GD, causing morbidity and impacting long-term quality...

Cite
Paskulin LD, Starosta RT, Bertholdo D, et al. Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment. Blood Cells Mol Dis. 2021;90:102591doi: 10.1016/j.bcmd.2021.102591.
Paskulin, L. D., Starosta, R. T., Bertholdo, D., Vairo, F. P., Vedolin, L., & Schwartz, I. V. D. (2021). Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment. Blood cells, molecules & diseases, 90102591. https://doi.org/10.1016/j.bcmd.2021.102591
Paskulin, Livia d'Ávila, et al. "Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment." Blood cells, molecules & diseases vol. 90 (2021): 102591. doi: https://doi.org/10.1016/j.bcmd.2021.102591
Paskulin LD, Starosta RT, Bertholdo D, Vairo FP, Vedolin L, Schwartz IVD. Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment. Blood Cells Mol Dis. 2021 Sep;90:102591. doi: 10.1016/j.bcmd.2021.102591. Epub 2021 Jul 01. PMID: 34242856.
Copy Download .nbib Format: NLM
Meigs' syndrome and adult-type granulosa cell tumor.

Taiwanese journal of obstetrics & gynecology

Yang ST, Cheng M, Lai CR, Shen SH, Lee WL, Wang PH.
PMID: 34794749
Taiwan J Obstet Gynecol. 2021 Nov;60(6):1116-1120. doi: 10.1016/j.tjog.2021.09.028.

OBJECTIVE: Adult-type granulosa cell tumors (GCT) are sex cord-stromal tumors and often accompanied with abdominal distention and hyperestrogenism-related symptoms. Adult-type GCT-presenting ascites and pleural effusion is extremely rare.CASE REPORT: A 56-year-old perimenopausal woman presented with abdominal distention and abnormal...

Cite
Yang ST, Cheng M, Lai CR, et al. Meigs' syndrome and adult-type granulosa cell tumor. Taiwan J Obstet Gynecol. 2021;60(6):1116-1120doi: 10.1016/j.tjog.2021.09.028.
Yang, S. T., Cheng, M., Lai, C. R., Shen, S. H., Lee, W. L., & Wang, P. H. (2021). Meigs' syndrome and adult-type granulosa cell tumor. Taiwanese journal of obstetrics & gynecology, 60(6), 1116-1120. https://doi.org/10.1016/j.tjog.2021.09.028
Yang, Szu-Ting, et al. "Meigs' syndrome and adult-type granulosa cell tumor." Taiwanese journal of obstetrics & gynecology vol. 60,6 (2021): 1116-1120. doi: https://doi.org/10.1016/j.tjog.2021.09.028
Yang ST, Cheng M, Lai CR, Shen SH, Lee WL, Wang PH. Meigs' syndrome and adult-type granulosa cell tumor. Taiwan J Obstet Gynecol. 2021 Nov;60(6):1116-1120. doi: 10.1016/j.tjog.2021.09.028. PMID: 34794749.
Copy Download .nbib Format: NLM
Does vertebral body tethering cause disc and facet joint degeneration? A preliminary MRI study with minimum two years follow-up.

The spine journal : official journal of the North American Spine Society

Yucekul A, Akpunarli B, Durbas A, Zulemyan T, Havlucu I, Ergene G, Senay S, Yalinay Dikmen P, Turgut Balci S, Karaarslan E, Yavuz Y, Yilgor C, Alanay A.
PMID: 34033932
Spine J. 2021 Nov;21(11):1793-1801. doi: 10.1016/j.spinee.2021.05.020. Epub 2021 May 23.

BACKGROUND CONTEXT: Vertebral body tethering (VBT), a flexible compression-based growth modulation technique, was claimed to prevent disc degeneration due to its less rigid nature compared to other growth-friendly techniques. Yet, the consequences of VBT surgery on discs and facet...

Cite
Yucekul A, Akpunarli B, Durbas A, et al. Does vertebral body tethering cause disc and facet joint degeneration? A preliminary MRI study with minimum two years follow-up. Spine J. 2021;21(11):1793-1801doi: 10.1016/j.spinee.2021.05.020.
Yucekul, A., Akpunarli, B., Durbas, A., Zulemyan, T., Havlucu, I., Ergene, G., Senay, S., Yalinay Dikmen, P., Turgut Balci, S., Karaarslan, E., Yavuz, Y., Yilgor, C., & Alanay, A. (2021). Does vertebral body tethering cause disc and facet joint degeneration? A preliminary MRI study with minimum two years follow-up. The spine journal : official journal of the North American Spine Society, 21(11), 1793-1801. https://doi.org/10.1016/j.spinee.2021.05.020
Yucekul, Altug, et al. "Does vertebral body tethering cause disc and facet joint degeneration? A preliminary MRI study with minimum two years follow-up." The spine journal : official journal of the North American Spine Society vol. 21,11 (2021): 1793-1801. doi: https://doi.org/10.1016/j.spinee.2021.05.020
Yucekul A, Akpunarli B, Durbas A, Zulemyan T, Havlucu I, Ergene G, Senay S, Yalinay Dikmen P, Turgut Balci S, Karaarslan E, Yavuz Y, Yilgor C, Alanay A. Does vertebral body tethering cause disc and facet joint degeneration? A preliminary MRI study with minimum two years follow-up. Spine J. 2021 Nov;21(11):1793-1801. doi: 10.1016/j.spinee.2021.05.020. Epub 2021 May 23. PMID: 34033932.
Copy Download .nbib Format: NLM
Showing 9985 to 9996 of 115915 entries